
Integra LifeSciences Faces Investor Probe After Revenue Guidance Cut
Shares of Integra LifeSciences plummeted 20 percent on October 2, 2026, after the medical technology firm slashed its annual revenue forecast. The sell-off follows a disclosure that July flooding at the company’s Cincinnati facility will disrupt manufacturing operations until the second quarter of 2027, contradicting earlier management assurances.

























